Epidemiology of pleural empyema in English hospitals and the impact of influenza
- PMID: 33334937
- PMCID: PMC8411895
- DOI: 10.1183/13993003.03546-2020
Epidemiology of pleural empyema in English hospitals and the impact of influenza
Abstract
Pleural empyema represents a significant healthcare burden due to extended hospital admissions and potential requirement for surgical intervention. This study aimed to assess changes in incidence and management of pleural empyema in England over the past 10 years and the potential impact of influenza on rates.Hospital Episode Statistics data were used to identify patients admitted to English hospitals with pleural empyema between 2008 and 2018. Linear regression was used to analyse the relationship between empyema rates and influenza incidence recorded by Public Health England. The relationship between influenza and empyema was further explored using serological data from a prospective cohort study of patients presenting with pleural empyema.Between April 2008 and March 2018 there were 55 530 patients admitted with pleural empyema. There was male predominance (67% versus 33%), which increased with age. Cases have increased significantly from 4447 in 2008 to 7268 in 2017. Peaks of incidence correlated moderately with rates of laboratory-confirmed influenza in children and young adults (r=0.30). For nine of the 10 years studied, the highest annual point incidence of influenza coincided with the highest admission rate for empyema (with a 2-week lag). In a cohort study of patients presenting to a single UK hospital with pleural empyema/infection, 24% (17 out of 72) had serological evidence of recent influenza infection, compared to 7% in seasonally matched controls with simple parapneumonic or cardiogenic effusions (p<0.001).Rates of empyema admissions in England have increased steadily with a seasonal variation that is temporally related to influenza incidence. Patient-level serological data from a prospective study support the hypothesis that influenza may play a pathogenic role in empyema development.
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.
Conflict of interest statement
Conflict of interest: D.T. Arnold has nothing to disclose. Conflict of interest: F.W. Hamilton has nothing to disclose. Conflict of interest: T.T. Morris has nothing to disclose. Conflict of interest: T. Suri has nothing to disclose. Conflict of interest: A. Morley has nothing to disclose. Conflict of interest: V. Frost has nothing to disclose. Conflict of interest: I.B. Vipond has nothing to disclose. Conflict of interest: A.R. Medford has nothing to disclose. Conflict of interest: R.A. Payne has nothing to disclose. Conflict of interest: P. Muir has nothing to disclose. Conflict of interest: N.A. Maskell has nothing to disclose.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous